Correction to: Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats (Molecular Neurobiology, (2025), 62, 4, (4520-4532), 10.1007/s12035-024-04569-8)

In the original web version of this article, several reference citations were not properly placed and these have been corrected as follows: of these effects appear to be more moderate than those of cocaine (for reviews, see [23, 27]). gene regulation in the striatum in adolescent rats [21, 23]… of serotonin receptors in the midbrain ([36, 44];… or other neuropsychiatric disorders [21, 53]… thus reflect different functional domains (see [65, 68], for details)… increase striatal gene expression (20 mg/kg/day, oral [49]; 5 mg/kg, i.p. [45, 46, 69, 70]), but potentiates… of fluoxetine (5 mg/kg), acutely or daily for 5–6 days [45, 46, 69, 70]… of these effects appear to be more moderate than those of cocaine (for reviews, see [23, 27]). gene regulation in the striatum in adolescent rats [21, 23]… of serotonin receptors in the midbrain ([36, 44];… or other neuropsychiatric disorders [21, 53]… thus reflect different functional domains (see [65, 68], for details)… increase striatal gene expression (20 mg/kg/day, oral [49]; 5 mg/kg, i.p. [45, 46, 69, 70]), but potentiates… of fluoxetine (5 mg/kg), acutely or daily for 5–6 days [45, 46, 69, 70]… The original article has been corrected.